End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,052
KRW
|
+1.15%
|
|
-0.28%
|
+15.35%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
71,754
|
79,681
|
99,501
|
121,059
|
66,960
|
54,122
|
Enterprise Value (EV)
1 |
79,485
|
55,557
|
77,443
|
109,244
|
55,011
|
38,839
|
P/E ratio
|
22.5
x
|
4.5
x
|
-21.2
x
|
-9.89
x
|
117
x
|
65.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.63
x
|
0.85
x
|
1.01
x
|
1.33
x
|
0.68
x
|
0.59
x
|
EV / Revenue
|
0.7
x
|
0.59
x
|
0.79
x
|
1.2
x
|
0.56
x
|
0.42
x
|
EV / EBITDA
|
14.2
x
|
52.5
x
|
32.3
x
|
-284
x
|
10.3
x
|
10.1
x
|
EV / FCF
|
-22.4
x
|
-302
x
|
-10.6
x
|
-13.1
x
|
14.5
x
|
10.4
x
|
FCF Yield
|
-4.47%
|
-0.33%
|
-9.44%
|
-7.64%
|
6.89%
|
9.64%
|
Price to Book
|
0.95
x
|
0.84
x
|
1.08
x
|
1.39
x
|
0.77
x
|
0.53
x
|
Nbr of stocks (in thousands)
|
40,654
|
40,654
|
41,459
|
44,344
|
44,344
|
59,344
|
Reference price
2 |
1,765
|
1,960
|
2,400
|
2,730
|
1,510
|
912.0
|
Announcement Date
|
15/03/19
|
16/03/20
|
22/03/21
|
21/03/22
|
20/03/23
|
18/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
114,047
|
94,032
|
98,301
|
91,101
|
98,048
|
91,429
|
EBITDA
1 |
5,586
|
1,059
|
2,400
|
-385
|
5,316
|
3,844
|
EBIT
1 |
2,488
|
-2,218
|
-700.1
|
-3,951
|
1,229
|
365.3
|
Operating Margin
|
2.18%
|
-2.36%
|
-0.71%
|
-4.34%
|
1.25%
|
0.4%
|
Earnings before Tax (EBT)
1 |
3,585
|
26,080
|
-2,831
|
-12,119
|
-837.9
|
497.9
|
Net income
1 |
3,187
|
18,821
|
-4,595
|
-12,239
|
570
|
710.3
|
Net margin
|
2.79%
|
20.02%
|
-4.67%
|
-13.43%
|
0.58%
|
0.78%
|
EPS
2 |
78.39
|
436.0
|
-113.2
|
-276.0
|
12.85
|
13.90
|
Free Cash Flow
1 |
-3,555
|
-184
|
-7,308
|
-8,346
|
3,788
|
3,745
|
FCF margin
|
-3.12%
|
-0.2%
|
-7.43%
|
-9.16%
|
3.86%
|
4.1%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
71.26%
|
97.41%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
664.6%
|
527.18%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/03/19
|
16/03/20
|
22/03/21
|
21/03/22
|
20/03/23
|
18/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
7,731
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
24,125
|
22,059
|
11,815
|
11,949
|
15,282
|
Leverage (Debt/EBITDA)
|
1.384
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-3,555
|
-184
|
-7,308
|
-8,346
|
3,788
|
3,745
|
ROE (net income / shareholders' equity)
|
4.18%
|
21.6%
|
-4.67%
|
-13.3%
|
0.53%
|
0.62%
|
ROA (Net income/ Total Assets)
|
1.23%
|
-1.06%
|
-0.34%
|
-2.11%
|
0.7%
|
0.2%
|
Assets
1 |
258,447
|
-1,777,288
|
1,355,166
|
579,236
|
81,665
|
356,047
|
Book Value Per Share
2 |
1,856
|
2,328
|
2,217
|
1,957
|
1,967
|
1,736
|
Cash Flow per Share
2 |
490.0
|
368.0
|
700.0
|
477.0
|
402.0
|
304.0
|
Capex
1 |
5,090
|
2,915
|
1,587
|
4,673
|
905
|
2,521
|
Capex / Sales
|
4.46%
|
3.1%
|
1.61%
|
5.13%
|
0.92%
|
2.76%
|
Announcement Date
|
15/03/19
|
16/03/20
|
22/03/21
|
21/03/22
|
20/03/23
|
18/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +15.35% | 45.75M | | +6.45% | 33.85B | | +25.16% | 8.37B | | +13.66% | 8.09B | | +26.95% | 5.71B | | +21.58% | 4.2B | | -7.95% | 4.03B | | +14.93% | 3.69B | | +12.21% | 3.68B | | -8.31% | 2.7B |
Testing & Measuring Equipment
|